h1

h2

h3

h4

h5
h6
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png

Comment on “Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives” by J.-X. Lu, H.-R. Lan, D. Zeng, J.-Y. Song, Y.-T. Hao, A.-P. Xing, A. Shen, and J. Yuan, RSC Adv., 2025, 15, 231–243



In
RSC Advances 15(52), Seiten/Artikel-Nr.:44437-44438

ImpressumLondon : RSC Publishing

ISSN2046-2069

Online
DOI: 10.1039/D5RA00388A

DOI: 10.1039/d5ra00388a


Einrichtungen

  1. Institut und Lehrstuhl für Molekulare Pathobiochemie, experimentelle Gentherapie und klinische Chemie (526000-3 ; 922420)

Projekte

  1. OAPKF - Open-Access-Publikation mit Unterstützung der RWTH Aachen University (021000-OAPKF) (021000-OAPKF)

Thematische Einordnung (Klassifikation)
DDC: 540


Dokumenttyp
Journal Article (Letter)

Format
online

Sprache
English

Anmerkung
No peer reviewed article

Externe Identnummern
WOS Core Collection: WOS:001615909400001
PubMed: pmid:41244744
SCOPUS: SCOPUS:2-s2.0-105026100861

Interne Identnummern
RWTH-2025-10078
Datensatz-ID: 1022514

Beteiligte Länder
Germany

Lizenzstatus der Zeitschrift

 GO


Medline ; DOAJ ; OpenAccess ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; National-Konsortium ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Articles
Faculty of Medicine (Fac.10)
Documents in print
526000\-3
Public records
Publication Charges

TypAmountVATCurrencyShareStatusCost centre
Other0.000.00EUR (Zahlung erfolgt)021000-922420
Sum0.000.00EUR   
Total0.00     
 Record created 2025-11-27, last modified 2026-08-20



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)